A study published in Nature Medicine revealed a link between postmenopausal blood protein signature and cognitive aging and Alzheimer’s risk. Meanwhile, a study in JAMA Network Open found that earlier menopause was associated with faster cognitive decline.
While menopause has been tied to cognitive symptoms like brain fog and mood changes, the latest findings point to potential biological pathways associated with brain aging.
The Nature Medicine study, which included nearly 15,000 women, identified 16 blood proteins that were upregulated in postmenopausal women. Levels of several inflammatory proteins were higher in women who experienced significant vasomotor symptoms. Among older women, those with the highest levels of these blood proteins experienced faster neurological decline and had a higher risk of Alzheimer’s disease.
Meanwhile, the JAMA Network Open study revealed that women who entered menopause earlier experienced faster rates of cognitive and episodic memory decline – with stronger associations among individuals who underwent surgical menopause.
With women accounting for roughly two-thirds of Alzheimer’s cases in the US, the latest findings could help inform standardized care pathways for long-term brain health around menopause, though more research is needed to understand how these factors may influence cognitive health.